{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:52:09Z","timestamp":1648723929637},"reference-count":11,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We have evaluated the utility of antineutrophil cytoplasmic antibodies and anti-\n            <jats:italic>Saccharomyces cerevisiae<\/jats:italic>\n            mannan antibodies for distinguishing Crohn's disease from ulcerative colitis and other diarrheal illnesses by evaluating sera from 396 patients. Sensitivity, specificity, and phenotypic correlations were investigated. The implications of our findings for implementing these tests in routine clinical testing are discussed.\n          <\/jats:p>","DOI":"10.1128\/cdli.12.11.1328-1330.2005","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T23:13:14Z","timestamp":1131405194000},"page":"1328-1330","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Serological Markers (Anti-\n            <i>Saccharomyces cerevisiae<\/i>\n            Mannan Antibodies and Antineutrophil Cytoplasmic Antibodies) in Inflammatory Bowel Disease: Diagnostic Utility and Phenotypic Correlation"],"prefix":"10.1128","volume":"12","author":[{"given":"M. S.","family":"Buckland","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom"},{"name":"Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mylonaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom"},{"name":"Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rampton","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom"},{"name":"Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Longhurst","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom"},{"name":"Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clim.2001.5145","volume":"102","year":"2002","unstructured":"Bartunkova, J., I. Kolarova, A. Sediva, and E. Holzelova. 2002. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin. Immunol.102:162-168.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004836-198808000-00011","volume":"10","year":"1988","unstructured":"Boirivant, M., M. Leoni, D. Tariciotti, S. Fais, O. Squarcia, and F. Pallone. 1988. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J. Clin. Gastroenterol.10:401-405.","journal-title":"J. Clin. Gastroenterol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","volume":"6","year":"2000","unstructured":"Gasche, C., J. Scholmerich, J. Brynskov, G. D'Haens, S. B. Hanauer, E. J. Irvine, D. P. Jewell, D. Rachmilewitz, D. B. Sachar, W. J. Sandborn, and L. R. Sutherland. 2000. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis.6:8-15.","journal-title":"Inflamm. Bowel Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/gut.2005.066860","volume":"54","year":"2005","unstructured":"Halfvarson, J., A. Standaert-Vitse, G. Jarnerot, B. Sendid, T. Jouault, L. Bodin, A. Duhamel, J. F. Colombel, C. Tysk, and D. Poulain. 2005. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut54:1237-1243.","journal-title":"Gut"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s005350300020","volume":"38","year":"2003","unstructured":"Hisabe, T., T. Matsui, T. Sakurai, Y. Murakami, H. Tanabe, H. Matake, T. Yao, S. Kamachi, and A. Iwashita. 2003. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J. Gastroenterol.38:121-126.","journal-title":"J. Gastroenterol."},{"key":"e_1_3_2_7_2","first-page":"201","volume":"51","year":"2005","unstructured":"Montanelli, A., E. Mainardi, A. Vagni, V. Villanacci, C. Zambelli, R. Cestari, P. Cengia, L. Minelli, and G. Missale. 2005. Immunological markers anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool. Minerva Gastroenterol. Dietol.51:201-207.","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jcp.48.4.346","volume":"48","year":"1995","unstructured":"Oudkerk Pool, M., G. Bouma, S. G. Meuwissen, B. M. von Blomberg, J. P. van de Merwe, W. L. Deville, J. C. Fonk, and A. S. Pena. 1995. Serological markers to differentiate between ulcerative colitis and Crohn's disease. J. Clin. Pathol.48:346-350.","journal-title":"J. Clin. Pathol."},{"key":"e_1_3_2_9_2","first-page":"23","volume":"14","year":"2005","unstructured":"Preda, C. M., M. Diculescu, V. Mirea, C. Marica, S. Vermeire, P. Rutgeerts, and A. Oproiu. 2005. Significance of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania. Rom. J. Gastroenterol.14:23-26.","journal-title":"Rom. J. Gastroenterol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","year":"1998","unstructured":"Quinton, J. F., B. Sendid, D. Reumaux, P. Duthilleul, A. Cortot, B. Grandbastien, G. Charrier, S. R. Targan, J. F. Colombel, and D. Poulain. 1998. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut42:788-791.","journal-title":"Gut"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2249.1999.00905.x","volume":"116","year":"1999","unstructured":"Roozendaal, C., and C. G. Kallenberg. 1999. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin. Exp. Immunol.116:206-213.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.46.1.58","volume":"46","year":"2000","unstructured":"Sutton, C. L., H. Yang, Z. Li, J. I. Rotter, S. R. Targan, and J. Braun. 2000. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut46:58-63.","journal-title":"Gut"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.11.1328-1330.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.11.1328-1330.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:35:18Z","timestamp":1627590918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.12.11.1328-1330.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1128\/CDLI.12.11.1328-1330.2005"],"URL":"https:\/\/doi.org\/10.1128\/cdli.12.11.1328-1330.2005","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"2005-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-09-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}